Journal article
P-526 Phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC)
Authors
Leighl N; Laurie S; Knox J; Ellis P; Shepherd F; Burkes R; Pond G; Zwiebel J; Moore M
Journal
Lung Cancer, Vol. 49, , pp. s255–s256
Publisher
Elsevier
Publication Date
July 2005
DOI
10.1016/s0169-5002(05)81019-0
ISSN
0169-5002